v3.26.3
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses        
Research and development $ 21,113 $ 21,968 $ 65,406 $ 84,359
General and administrative 4,700 4,545 14,112 14,274
Total operating expenses 25,813 26,513 79,518 98,633
Loss from operations (25,813) (26,513) (79,518) (98,633)
Other income (expense)        
Interest income 812 1,639 2,987 6,125
Interest expense (999) (1,068) (3,162) (3,137)
Change in fair value of embedded derivatives 650 (440) 950 (290)
Other expense, net (19) (69) (81) (262)
Total other income 444 62 694 2,436
Net loss (25,369) (26,451) (78,824) (96,197)
Other comprehensive gain (loss)        
Unrealized (loss) gain on marketable securities (12) 86 (108) 157
Comprehensive loss $ (25,381) $ (26,365) $ (78,932) $ (96,040)
Net loss per common share, basic (in dollars per share) $ (0.35) $ (0.44) $ (1.14) $ (1.59)
Net loss per common share, diluted (in dollars per share) $ (0.35) $ (0.44) $ (1.14) $ (1.59)
Weighted-average shares outstanding, basic (in shares) 72,321,459 60,573,425 69,297,155 60,557,668
Weighted-average shares outstanding, diluted (in shares) 72,321,459 60,573,425 69,297,155 60,557,668